{"id":"https://openalex.org/W7222924099","doi":"https://doi.org/10.3390/immuno6040069","title":"Clinical Outcomes and Tumor Immune Microenvironment in Epstein\u2013Barr Virus-Positive Gastroesophageal Adenocarcinoma Treated with Immune Checkpoint Inhibitors","display_name":"Clinical Outcomes and Tumor Immune Microenvironment in Epstein\u2013Barr Virus-Positive Gastroesophageal Adenocarcinoma Treated with Immune Checkpoint Inhibitors","publication_year":2026,"publication_date":"2026-10-18","ids":{"openalex":"https://openalex.org/W7222924099","doi":"https://doi.org/10.3390/immuno6040069"},"language":"en","primary_location":{"id":"doi:10.3390/immuno6040069","doi":"https://doi.org/10.3390/immuno6040069","is_oa":true,"landing_page_url":"https://doi.org/10.3390/immuno6040069","pdf_url":null,"source":{"id":"https://openalex.org/S4210218519","display_name":"Immuno","issn_l":"2673-5601","issn":["2673-5601"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj"],"host_organization":"https://openalex.org/P4310310987","host_organization_name":"Multidisciplinary Digital Publishing Institute","host_organization_lineage":["https://openalex.org/P4310310987"],"host_organization_lineage_names":["Multidisciplinary Digital Publishing Institute"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Immuno","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.3390/immuno6040069","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5075192736","display_name":"Jes\u00fas Yaringa\u00f1o","orcid":"https://orcid.org/0009-0004-4275-1563","observed_orcids":["https://orcid.org/0009-0004-4275-1563"]},"institutions":[{"id":"https://openalex.org/I4210127641","display_name":"Vall d'Hebron Hospital Universitari","ror":"https://ror.org/03ba28x55","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I157913058","https://openalex.org/I4210127641","https://openalex.org/I4210153292"]},{"id":"https://openalex.org/I4387155398","display_name":"Vall d'Hebron Institute of Oncology","ror":"https://ror.org/054xx3904","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4387153040","https://openalex.org/I4387155398"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Jes\u00fas Yaringa\u00f1o","raw_affiliation_strings":["Hereditary Cancer Genetics Group, Vall d\u2019Hebron Institute of Oncology, 08035 Barcelona, Spain","Medical Oncology Department, Vall d\u2019Hebron University Hospital, 08035 Barcelona, Spain"],"raw_orcid":"https://orcid.org/0009-0004-4275-1563","affiliations":[{"raw_affiliation_string":"Hereditary Cancer Genetics Group, Vall d\u2019Hebron Institute of Oncology, 08035 Barcelona, Spain","institution_ids":["https://openalex.org/I4387155398"]},{"raw_affiliation_string":"Medical Oncology Department, Vall d\u2019Hebron University Hospital, 08035 Barcelona, Spain","institution_ids":["https://openalex.org/I4210127641"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079339385","display_name":"Stefania Landolfi","orcid":"https://orcid.org/0000-0002-1059-635X","observed_orcids":["https://orcid.org/0000-0002-1059-635X"]},"institutions":[{"id":"https://openalex.org/I4210127641","display_name":"Vall d'Hebron Hospital Universitari","ror":"https://ror.org/03ba28x55","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I157913058","https://openalex.org/I4210127641","https://openalex.org/I4210153292"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Stefania Landolfi","raw_affiliation_strings":["Pathology Department, Vall d\u2019Hebron University Hospital, 08035 Barcelona, Spain"],"raw_orcid":"https://orcid.org/0000-0002-1059-635X","affiliations":[{"raw_affiliation_string":"Pathology Department, Vall d\u2019Hebron University Hospital, 08035 Barcelona, Spain","institution_ids":["https://openalex.org/I4210127641"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042601272","display_name":"Roberta Fasani","orcid":"https://orcid.org/0000-0003-1630-9988","observed_orcids":["https://orcid.org/0000-0003-1630-9988"]},"institutions":[{"id":"https://openalex.org/I4387155398","display_name":"Vall d'Hebron Institute of Oncology","ror":"https://ror.org/054xx3904","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4387153040","https://openalex.org/I4387155398"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Roberta Fasani","raw_affiliation_strings":["Molecular Oncology Group, Vall d\u2019Hebron Institute of Oncology, 08035 Barcelona, Spain"],"raw_orcid":"https://orcid.org/0000-0003-1630-9988","affiliations":[{"raw_affiliation_string":"Molecular Oncology Group, Vall d\u2019Hebron Institute of Oncology, 08035 Barcelona, Spain","institution_ids":["https://openalex.org/I4387155398"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5159047883","display_name":"Daniel Acosta","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210127641","display_name":"Vall d'Hebron Hospital Universitari","ror":"https://ror.org/03ba28x55","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I157913058","https://openalex.org/I4210127641","https://openalex.org/I4210153292"]},{"id":"https://openalex.org/I4387155398","display_name":"Vall d'Hebron Institute of Oncology","ror":"https://ror.org/054xx3904","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4387153040","https://openalex.org/I4387155398"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Daniel Acosta","raw_affiliation_strings":["Digestive Tumors Unit, Vall d\u2019Hebron University Hospital, 08035 Barcelona, Spain","Gastrointestinal Tract Tumors Group, Vall d\u2019Hebron Institute of Oncology, 08035 Barcelona, Spain","Medical Oncology Department, Vall d\u2019Hebron University Hospital, 08035 Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Digestive Tumors Unit, Vall d\u2019Hebron University Hospital, 08035 Barcelona, Spain","institution_ids":["https://openalex.org/I4210127641"]},{"raw_affiliation_string":"Gastrointestinal Tract Tumors Group, Vall d\u2019Hebron Institute of Oncology, 08035 Barcelona, Spain","institution_ids":["https://openalex.org/I4387155398"]},{"raw_affiliation_string":"Medical Oncology Department, Vall d\u2019Hebron University Hospital, 08035 Barcelona, Spain","institution_ids":["https://openalex.org/I4210127641"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011343932","display_name":"Diego Ferreira Santana","orcid":"https://orcid.org/0009-0009-8408-1269","observed_orcids":["https://orcid.org/0009-0009-8408-1269"]},"institutions":[{"id":"https://openalex.org/I180910786","display_name":"Universidad de la Rep\u00fablica de Uruguay","ror":"https://ror.org/030bbe882","country_code":"UY","type":"education","lineage":["https://openalex.org/I180910786"]},{"id":"https://openalex.org/I4210154927","display_name":"Hospital de Cl\u00ednicas","ror":"https://ror.org/04jdthe46","country_code":"UY","type":"healthcare","lineage":["https://openalex.org/I4210154927"]}],"countries":["UY"],"is_corresponding":false,"raw_author_name":"Diego Santana","raw_affiliation_strings":["Medical Oncology Department, Hospital de Cl\u00ednicas \u2018Dr. Manuel Quintela\u2019, Facultad de Medicina, Universidad de la Rep\u00fablica, Montevideo11600, Uruguay"],"raw_orcid":"https://orcid.org/0009-0009-8408-1269","affiliations":[{"raw_affiliation_string":"Medical Oncology Department, Hospital de Cl\u00ednicas \u2018Dr. Manuel Quintela\u2019, Facultad de Medicina, Universidad de la Rep\u00fablica, Montevideo11600, Uruguay","institution_ids":["https://openalex.org/I180910786","https://openalex.org/I4210154927"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081251210","display_name":"Sandra Castro","orcid":"https://orcid.org/0000-0001-8518-749X","observed_orcids":["https://orcid.org/0000-0001-8518-749X"]},"institutions":[{"id":"https://openalex.org/I4210127641","display_name":"Vall d'Hebron Hospital Universitari","ror":"https://ror.org/03ba28x55","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I157913058","https://openalex.org/I4210127641","https://openalex.org/I4210153292"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Sandra Castro-Boix","raw_affiliation_strings":["Esophagogastric Surgery Unit, General and Digestive Surgery Department, Vall d\u2019Hebron University Hospital, 08035 Barcelona, Spain"],"raw_orcid":"https://orcid.org/0000-0001-8518-749X","affiliations":[{"raw_affiliation_string":"Esophagogastric Surgery Unit, General and Digestive Surgery Department, Vall d\u2019Hebron University Hospital, 08035 Barcelona, Spain","institution_ids":["https://openalex.org/I4210127641"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081259888","display_name":"Paolo Giovanni Nuciforo","orcid":"https://orcid.org/0000-0003-1380-0990","observed_orcids":["https://orcid.org/0000-0003-1380-0990"]},"institutions":[{"id":"https://openalex.org/I4387155398","display_name":"Vall d'Hebron Institute of Oncology","ror":"https://ror.org/054xx3904","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4387153040","https://openalex.org/I4387155398"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Paolo Nuciforo","raw_affiliation_strings":["Molecular Oncology Group, Vall d\u2019Hebron Institute of Oncology, 08035 Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Molecular Oncology Group, Vall d\u2019Hebron Institute of Oncology, 08035 Barcelona, Spain","institution_ids":["https://openalex.org/I4387155398"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015190461","display_name":"Josep M. Tabernero","orcid":"https://orcid.org/0000-0002-2495-8139","observed_orcids":["https://orcid.org/0000-0002-2495-8139"]},"institutions":[{"id":"https://openalex.org/I4210127641","display_name":"Vall d'Hebron Hospital Universitari","ror":"https://ror.org/03ba28x55","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I157913058","https://openalex.org/I4210127641","https://openalex.org/I4210153292"]},{"id":"https://openalex.org/I4387155398","display_name":"Vall d'Hebron Institute of Oncology","ror":"https://ror.org/054xx3904","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4387153040","https://openalex.org/I4387155398"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Josep Tabernero","raw_affiliation_strings":["Digestive Tumors Unit, Vall d\u2019Hebron University Hospital, 08035 Barcelona, Spain","Gastrointestinal Tract Tumors Group, Vall d\u2019Hebron Institute of Oncology, 08035 Barcelona, Spain","Medical Oncology Department, Vall d\u2019Hebron University Hospital, 08035 Barcelona, Spain"],"raw_orcid":"https://orcid.org/0000-0002-2495-8139","affiliations":[{"raw_affiliation_string":"Digestive Tumors Unit, Vall d\u2019Hebron University Hospital, 08035 Barcelona, Spain","institution_ids":["https://openalex.org/I4210127641"]},{"raw_affiliation_string":"Gastrointestinal Tract Tumors Group, Vall d\u2019Hebron Institute of Oncology, 08035 Barcelona, Spain","institution_ids":["https://openalex.org/I4387155398"]},{"raw_affiliation_string":"Medical Oncology Department, Vall d\u2019Hebron University Hospital, 08035 Barcelona, Spain","institution_ids":["https://openalex.org/I4210127641"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030657436","display_name":"Elena \u00c9lez","orcid":"https://orcid.org/0000-0002-4653-6324","observed_orcids":["https://orcid.org/0000-0002-4653-6324","https://orcid.org/0000-0002-9178-0246"]},"institutions":[{"id":"https://openalex.org/I4210127641","display_name":"Vall d'Hebron Hospital Universitari","ror":"https://ror.org/03ba28x55","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I157913058","https://openalex.org/I4210127641","https://openalex.org/I4210153292"]},{"id":"https://openalex.org/I4387155398","display_name":"Vall d'Hebron Institute of Oncology","ror":"https://ror.org/054xx3904","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4387153040","https://openalex.org/I4387155398"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Elena \u00c9lez","raw_affiliation_strings":["Digestive Tumors Unit, Vall d\u2019Hebron University Hospital, 08035 Barcelona, Spain","Gastrointestinal Tract Tumors Group, Vall d\u2019Hebron Institute of Oncology, 08035 Barcelona, Spain","Medical Oncology Department, Vall d\u2019Hebron University Hospital, 08035 Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Digestive Tumors Unit, Vall d\u2019Hebron University Hospital, 08035 Barcelona, Spain","institution_ids":["https://openalex.org/I4210127641"]},{"raw_affiliation_string":"Gastrointestinal Tract Tumors Group, Vall d\u2019Hebron Institute of Oncology, 08035 Barcelona, Spain","institution_ids":["https://openalex.org/I4387155398"]},{"raw_affiliation_string":"Medical Oncology Department, Vall d\u2019Hebron University Hospital, 08035 Barcelona, Spain","institution_ids":["https://openalex.org/I4210127641"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5035771371","display_name":"Eduardo Ter\u00e1n","orcid":"https://orcid.org/0000-0001-5643-6506","observed_orcids":["https://orcid.org/0000-0001-5643-6506"]},"institutions":[{"id":"https://openalex.org/I4210127641","display_name":"Vall d'Hebron Hospital Universitari","ror":"https://ror.org/03ba28x55","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I157913058","https://openalex.org/I4210127641","https://openalex.org/I4210153292"]},{"id":"https://openalex.org/I4387155398","display_name":"Vall d'Hebron Institute of Oncology","ror":"https://ror.org/054xx3904","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4387153040","https://openalex.org/I4387155398"]}],"countries":["ES"],"is_corresponding":true,"raw_author_name":"Eduardo Ter\u00e1n","raw_affiliation_strings":["Digestive Tumors Unit, Vall d\u2019Hebron University Hospital, 08035 Barcelona, Spain","Gastrointestinal Tract Tumors Group, Vall d\u2019Hebron Institute of Oncology, 08035 Barcelona, Spain","Medical Oncology Department, Vall d\u2019Hebron University Hospital, 08035 Barcelona, Spain"],"raw_orcid":"https://orcid.org/0000-0001-5643-6506","affiliations":[{"raw_affiliation_string":"Digestive Tumors Unit, Vall d\u2019Hebron University Hospital, 08035 Barcelona, Spain","institution_ids":["https://openalex.org/I4210127641"]},{"raw_affiliation_string":"Gastrointestinal Tract Tumors Group, Vall d\u2019Hebron Institute of Oncology, 08035 Barcelona, Spain","institution_ids":["https://openalex.org/I4387155398"]},{"raw_affiliation_string":"Medical Oncology Department, Vall d\u2019Hebron University Hospital, 08035 Barcelona, Spain","institution_ids":["https://openalex.org/I4210127641"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5035771371"],"corresponding_institution_ids":["https://openalex.org/I4210127641","https://openalex.org/I4387155398"],"apc_list":{"value":1000,"currency":"CHF","value_usd":1207},"apc_paid":{"value":1000,"currency":"CHF","value_usd":1207},"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"6","issue":"4","first_page":"69","last_page":"69"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.8438000082969666,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.8438000082969666,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10685","display_name":"Viral-associated cancers and disorders","score":0.11879999935626984,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10619","display_name":"Esophageal Cancer Research and Treatment","score":0.009600000455975533,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.9869999885559082},{"id":"https://openalex.org/keywords/tumor-immune-microenvironment","display_name":"tumor immune microenvironment","score":0.9850000143051147},{"id":"https://openalex.org/keywords/pd-l1","display_name":"PD-L1","score":0.8259999752044678},{"id":"https://openalex.org/keywords/pd-l2","display_name":"PD-L2","score":0.8569999933242798},{"id":"https://openalex.org/keywords/ebv-encoded-rna","display_name":"EBV-encoded RNA","score":0.8420000076293945},{"id":"https://openalex.org/keywords/immunotherapy-response","display_name":"immunotherapy response","score":0.7409999966621399},{"id":"https://openalex.org/keywords/predictive-biomarkers","display_name":"predictive biomarkers","score":0.6679999828338623},{"id":"https://openalex.org/keywords/her2","display_name":"HER2","score":0.7720000147819519},{"id":"https://openalex.org/keywords/claudin-18-2","display_name":"claudin 18.2","score":0.9760000109672546},{"id":"https://openalex.org/keywords/dna-mismatch-repair","display_name":"DNA mismatch repair","score":0.8930000066757202}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8287000060081482},{"id":"https://openalex.org/C2776107976","wikidata":"https://www.wikidata.org/wiki/Q1786433","display_name":"Tumor microenvironment","level":3,"score":0.6822999715805054},{"id":"https://openalex.org/C2780851360","wikidata":"https://www.wikidata.org/wiki/Q21686041","display_name":"Immune checkpoint","level":4,"score":0.6262000203132629},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.5771999955177307},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5680000185966492},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5370000004768372},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.4887000024318695},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4787999987602234},{"id":"https://openalex.org/C2781182431","wikidata":"https://www.wikidata.org/wiki/Q356033","display_name":"Adenocarcinoma","level":3,"score":0.4742000102996826},{"id":"https://openalex.org/C167135981","wikidata":"https://www.wikidata.org/wiki/Q2146302","display_name":"Retrospective cohort study","level":2,"score":0.46799999475479126},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.4124999940395355},{"id":"https://openalex.org/C2778822529","wikidata":"https://www.wikidata.org/wiki/Q1951525","display_name":"Progressive disease","level":3,"score":0.38769999146461487},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.37619999051094055},{"id":"https://openalex.org/C2781197716","wikidata":"https://www.wikidata.org/wiki/Q864574","display_name":"Biomarker","level":2,"score":0.37459999322891235},{"id":"https://openalex.org/C2781053074","wikidata":"https://www.wikidata.org/wiki/Q21100639","display_name":"PD-L1","level":4,"score":0.3610000014305115},{"id":"https://openalex.org/C2776283816","wikidata":"https://www.wikidata.org/wiki/Q332823","display_name":"Survival rate","level":2,"score":0.32199999690055847},{"id":"https://openalex.org/C2780030458","wikidata":"https://www.wikidata.org/wiki/Q7041828","display_name":"Nivolumab","level":4,"score":0.3140999972820282},{"id":"https://openalex.org/C3019096185","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Complete response","level":3,"score":0.3059999942779541},{"id":"https://openalex.org/C204232928","wikidata":"https://www.wikidata.org/wiki/Q899285","display_name":"Immunohistochemistry","level":2,"score":0.2989000082015991},{"id":"https://openalex.org/C21705690","wikidata":"https://www.wikidata.org/wiki/Q2907609","display_name":"CTLA-4","level":4,"score":0.28299999237060547},{"id":"https://openalex.org/C146357865","wikidata":"https://www.wikidata.org/wiki/Q1123245","display_name":"Stage (stratigraphy)","level":2,"score":0.28119999170303345},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.28049999475479126},{"id":"https://openalex.org/C10515644","wikidata":"https://www.wikidata.org/wiki/Q543310","display_name":"Survival analysis","level":2,"score":0.27469998598098755}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.3390/immuno6040069","doi":"https://doi.org/10.3390/immuno6040069","is_oa":true,"landing_page_url":"https://doi.org/10.3390/immuno6040069","pdf_url":null,"source":{"id":"https://openalex.org/S4210218519","display_name":"Immuno","issn_l":"2673-5601","issn":["2673-5601"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj"],"host_organization":"https://openalex.org/P4310310987","host_organization_name":"Multidisciplinary Digital Publishing Institute","host_organization_lineage":["https://openalex.org/P4310310987"],"host_organization_lineage_names":["Multidisciplinary Digital Publishing Institute"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Immuno","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.3390/immuno6040069","doi":"https://doi.org/10.3390/immuno6040069","is_oa":true,"landing_page_url":"https://doi.org/10.3390/immuno6040069","pdf_url":null,"source":{"id":"https://openalex.org/S4210218519","display_name":"Immuno","issn_l":"2673-5601","issn":["2673-5601"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj"],"host_organization":"https://openalex.org/P4310310987","host_organization_name":"Multidisciplinary Digital Publishing Institute","host_organization_lineage":["https://openalex.org/P4310310987"],"host_organization_lineage_names":["Multidisciplinary Digital Publishing Institute"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Immuno","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":25,"referenced_works":["https://openalex.org/W1985896550","https://openalex.org/W2126547130","https://openalex.org/W2556376431","https://openalex.org/W2737578400","https://openalex.org/W2767612092","https://openalex.org/W2884397450","https://openalex.org/W3022265620","https://openalex.org/W3118745315","https://openalex.org/W3126660905","https://openalex.org/W3147142721","https://openalex.org/W3171517418","https://openalex.org/W3211325671","https://openalex.org/W4214810944","https://openalex.org/W4220714364","https://openalex.org/W4353085202","https://openalex.org/W4365813058","https://openalex.org/W4385429828","https://openalex.org/W4387849849","https://openalex.org/W4388526701","https://openalex.org/W4390543751","https://openalex.org/W4401958406","https://openalex.org/W4403527409","https://openalex.org/W4408236029","https://openalex.org/W4410816334","https://openalex.org/W7125837225"],"related_works":["https://openalex.org/W7154010009","https://openalex.org/W3217458603","https://openalex.org/W4404603365","https://openalex.org/W4391895563","https://openalex.org/W4304191812","https://openalex.org/W4410814921","https://openalex.org/W7160831416","https://openalex.org/W4392499439","https://openalex.org/W4362474475","https://openalex.org/W3009140068"],"abstract_inverted_index":{"Epstein\u2013Barr":[0,88],"virus-positive":[1],"gastroesophageal":[2],"adenocarcinoma":[3],"(EBV-GEA)":[4],"is":[5,45],"a":[6,28,72],"distinct":[7],"molecular":[8,98,260],"subtype":[9],"characterized":[10,138],"by":[11,87,139,216],"recurrent":[12],"genomic":[13],"and":[14,20,42,80,97,118,144,158,169,220,255],"epigenetic":[15],"alterations,":[16],"frequent":[17],"PD-L1/PD-L2":[18],"upregulation,":[19],"an":[21,50],"immune-enriched":[22],"tumor":[23,130,133],"microenvironment.":[24],"These":[25],"features":[26],"provide":[27],"strong":[29],"biological":[30,256],"rationale":[31],"for":[32,54],"immune":[33,134,181],"checkpoint":[34],"inhibition":[35],"(ICI);":[36],"however,":[37],"clinical":[38,167,208,254],"evidence":[39],"remains":[40],"limited,":[41],"EBV":[43,83],"positivity":[44,84],"not":[46,250],"currently":[47],"established":[48],"as":[49],"independent":[51],"predictive":[52],"biomarker":[53],"immunotherapy.":[55],"We":[56],"retrospectively":[57],"identified":[58],"consecutive":[59],"patients":[60,127,149,192],"with":[61,68,128,150,193],"locally":[62],"advanced":[63],"or":[64,174],"metastatic":[65],"EBV-GEA":[66,151],"treated":[67],"ICI-based":[69,234],"regimens":[70],"at":[71],"single":[73],"tertiary":[74],"cancer":[75],"center":[76],"between":[77,166],"January":[78],"2016":[79],"August":[81],"2025.":[82],"was":[85,124,136,156,161,178,184,249],"confirmed":[86],"virus-encoded":[89],"RNA":[90],"in":[91,186,240],"situ":[92],"hybridization.":[93],"Clinical,":[94],"pathological,":[95],"treatment,":[96],"data":[99],"were":[100,152],"collected.":[101],"Treatment":[102],"outcomes":[103],"included":[104],"best":[105],"overall":[106],"response,":[107],"objective":[108],"response":[109,219],"rate":[110,114],"(ORR),":[111],"disease":[112],"control":[113],"(DCR),":[115],"progression-free":[116],"survival":[117,120],"disease-free":[119],"when":[121],"curative-intent":[122],"surgery":[123],"performed.":[125],"In":[126,225],"adequate":[129],"tissue,":[131],"the":[132,159,190,194,205],"microenvironment":[135,182],"exploratorily":[137],"immunohistochemical":[140],"quantification":[141],"of":[142,245],"CD3+":[143,196],"CD8+":[145,227],"T-cell":[146,197,228],"densities.":[147],"Eight":[148],"included.":[153],"The":[154],"ORR":[155],"62.5%":[157],"DCR":[160],"75%.":[162],"No":[163],"consistent":[164],"relationship":[165],"outcome":[168],"HER2,":[170],"PD-L1,":[171],"Claudin":[172],"18.2":[173],"mismatch":[175],"repair":[176],"status":[177],"observed.":[179],"Tumor":[180],"assessment":[183],"feasible":[185],"five":[187],"patients.":[188],"Notably,":[189],"three":[191],"highest":[195],"densities":[198],"(>2000":[199],"cells/mm2,":[200],"post":[201],"hoc":[202],"threshold)":[203],"experienced":[204],"most":[206],"favorable":[207],"outcomes,":[209],"including":[210],"two":[211],"radiological":[212],"partial":[213,223],"responses":[214],"followed":[215],"pathologic":[217],"complete":[218],"one":[221],"prolonged":[222],"response.":[224],"contrast,":[226],"density":[229],"showed":[230],"greater":[231],"interpatient":[232],"variability.":[233],"therapy":[235],"demonstrated":[236],"clinically":[237],"meaningful":[238],"activity":[239],"this":[241,259],"small":[242],"retrospective":[243],"cohort":[244],"EBV-GEA,":[246],"but":[247],"benefit":[248],"universal,":[251],"highlighting":[252],"substantial":[253],"heterogeneity":[257],"within":[258],"subtype.":[261]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2026-10-20T00:00:00"}